Background
==========

Recent World Health Organization (WHO) guidelines recommend a universal \'test and treat\' strategy for malaria, mainly by use of rapid diagnostic test (RDT) and microscopy in all transmission areas \[[@B1]\]. In rural settings, however, febrile outpatients present with multiple complaints at health facilities and receive antibiotics in addition to anti-malarial treatment. Although WHO recommends rational use of medicines, it is estimated that in developing countries, the proportion of patients treated according to clinical guidelines for common diseases in primary care is less than 40% in the public sector and 30% in the private sector \[[@B2]\].

Antibiotics are routinely prescribed for colds, non-specific upper respiratory tract infections and acute bronchitis \[[@B3],[@B4]\], as concomitant medications to anti-malarials \[[@B5]\]. In almost all cases, these are viral, self-limited conditions in which antibiotic use does not enhance illness resolution and is not recommended \[[@B6],[@B7]\]. For other infections, such as otitis media, antibiotics provide some benefit, but the value of their use as first-line treatment has been debated \[[@B8]\].

Even for conditions in which antibiotic use might be justified, experts have expressed concern about substantial overuse \[[@B4]\] that impacts on health care costs. Inappropriate use of these drugs promotes antimicrobial resistance \[[@B9]\], adverse drug reactions and erodes patient confidence in health services \[[@B2]\]. In absence of urgent and corrective actions, the world is heading towards a post-antibiotic era in which many common infections will no longer have a cure and, once again, kill unabated \[[@B10],[@B11]\].

Although the Uganda national malaria guidelines now recommend confirmation of parasitaemia before initiation of treatment, data on how results of use of malaria diagnostics influence antibiotic treatment among febrile outpatients is lacking. The current study assessed antibiotic prescribing rates among febrile outpatients attending rural health centres (HCs) where feasibility of rolling out parasitological diagnosis for malaria was being tested. The primary outcome measures were the proportions of patients with febrile illness that were prescribed antibiotics when: not tested for malaria, they test positive and when they test negative.

Methods
=======

Study design
------------

Data collection on antibiotic treatment was carried out within a cluster randomized feasibility trial of presumptive malaria diagnosis (control) and two diagnostic interventions (microscopy and RDT). Fifteen out of twenty sub-county level government HCs in a district of low malaria endemicity in Uganda were randomly selected for the trial. HCs were the primary sampling units, and were allocated to the three diagnostic arms using simple randomization. Finally, there were five HCs per arm (diagnostic method in a defined group of patients).

Setting
-------

The trial was carried out in Bushenyi district in south-western Uganda. The district headquarter is located at about 320 km from the capital city Kampala. The district is mainly rural with a total land area of 3,949 sq. km. It is endowed with diverse natural resources that include arable land, forests, large lake water bodies (Lakes Edward, George and Kazinga Channel), Queen Elizabeth National Park and minerals. The main economic activities are semi-intensive agriculture (growing crops and rearing animals), fishing and trade. The district is multi-ethnic with varying customs and norms. The main inhabitants are Banyankore and Bakiga. The total population is estimated at 731,392, and with 20 public HCs at sub-county level. The population distribution and density varies with physical geography. It is concentrated in the low-lying plateau zones of Sheema, Igara and Ruhinda; and sparse in the hilly-rough and rugged terrain of Buhweju and Bunyaruguru. The climate is relatively wet. The mean annual temperature range is 12.5°-30°C. Most of the district receives 1500-2000 mm of rainfall annually. Although Bushenyi experiences low and unstable malaria transmission, people of all ages are at risk. It is epidemic-prone, with occasional malaria outbreaks occurring shortly after the rains. The annual entomological inoculation rate is not known, but it was reported to be \< 10 infective bites per person per year in the neighbouring district of Kanungu \[[@B12]\]. The trial commenced before Bushenyi was partitioned. However, partitioning did not affect the status of the trial HCs and the delivery of health services by the end of data collection. Additional description of the study setting has been published previously \[[@B13]\].

Study procedures
----------------

### Training of staff

A total of 74 clinical and laboratory staff received a one-day refresher training on-site. The training and subsequent study procedures were a scale-up of activities performed during the assessment of the accuracy of these malaria diagnostic methods \[[@B14]\]. All staff members were trained in theory by re-orienting them to the malaria treatment policy. Staff in the control arm were only re-oriented to the current malaria treatment guidelines but testing of patients was not performed. In the microscopy arm, members were, in addition, trained in 1) finger prick for collection of blood, 2) thick/thin blood smear preparation, 3) staining smears, and 4) blood smear reading. In the RDT arm, the staff were in addition, trained in 1) finger prick for collection of blood and 2) preparation and reading of *Paracheck^®^*. The staff in HCs with microscopy or RDT were instructed to treat patients for malaria according to test results. Treatment with antibiotics followed national guidelines. HC outpatient registers were modified to record additional variables such as the presenting complaints, drugs dispensed and to indicate those prescribed but out-of stock. The trained staff were charged with training those that were off-duty on the day of training. However, additional clarification was provided during supervision. Supervision by the study team was carried out weekly during the first two months and monthly thereafter. The district laboratory focal persons provided the routine quality control procedures in both microscopy and RDT arms.

Description of the diagnostic arms
----------------------------------

### Presumptive (control) arm

Patients presenting with fever (by statement or measured) were enrolled to receive service without parasitological confirmation of malaria. Patients were treated on the basis of signs and symptoms only.

### Microscopy arm

All patients presenting with fever (by statement or measured) were enrolled. The laboratory assistants prepared thick and thin blood smears by finger-prick using sterile blood lancets on separate frosted slides. Standard staining was performed using the Field\'s stain method. Laboratory assistants were only familiar with this staining technique. Blood films were read at magnification X1,000. Each film was graded as positive (asexual malaria parasites seen) or negative (no malaria parasites seen) based on inspection of 200 fields. Microscopy test results were recorded in the laboratory registers.

Rapid diagnostic test arm
-------------------------

Patients presenting with fever underwent rapid testing with the \"*Paracheck^®^*\" device (Orchid Biomedical Systems, Goa, India). *Paracheck Pf^®^*is based on the detection of histidine rich protein-2 (Pf HRP-2) produced by *Plasmodium falciparum*trophozoites and young gametocytes. The specimens were drawn by trained nurses or laboratory assistants using a simple finger-prick. The test preparation and interpretation were done following manufacturer\'s instructions and standard operating procedures. The test was considered positive when the antigen line was visible in the test window and negative when only the control band was visible. RDT results were recorded in the outpatient registers.

Data collection
---------------

All outpatients presenting at the study HCs with fever (by statement or measured) from March 2010 to July 2011 were enrolled. Data collection was carried out weekly by the research assistants by extracting information from the laboratory and outpatient registers.

Statistical analysis
--------------------

The collected data were manually checked and cleaned. Data were double entered by two trained database assistants in a customized entry template with in-built consistency checks in EpiData 3.1 software (The EpiData Association, Odense, Denmark). The two data sets were validated to check for entry errors. Before analysis in Stata version 10 (Stata Corp LP, College Station, Texas, USA), the data were declared a cluster design using the \"svyset command\" with HCs as primary sampling units. Further, the Poisson regression model was fitted while accounting for clustering. Probability values (*p*-values) were set at 0.05 and confidence intervals (CI) were calculated at the 95% level. Socio-demographic and symptom data were presented using descriptive statistics: distribution by age, number and percent of patients with positive and negative results, and those receiving drugs.

Ethical approval
----------------

The study was approved by Makerere University School of Public Health Higher Degrees Research and Ethics Committee; and the Uganda National Council for Science and Technology (Ref: HS 209). The study was registered with the Clinicaltrials.gov (NCT00565071).

Results
=======

Description of the study population
-----------------------------------

The study was carried out in 15 sub-county level government HCs located in an area of low malaria transmission intensity. Overall, 52,116 outpatients presenting with fever were enrolled: in the presumptive arm 16,971; microscopy arm 17,508; and RDT arm 17,637 (Figure [1](#F1){ref-type="fig"}). There were 8,552 children under five years (16.4%) with a median age of two \[inter-quartile range one to three years\]. The median age for those five years and above was 21 \[inter-quartile range 13-34 years\]. The overall age range was five months to ninety five years. The presenting symptoms of patients are presented in Table [1](#T1){ref-type="table"}.

![**Study profile**.](1475-2875-10-377-1){#F1}

###### 

Selected characteristics of study sample

  ----------------------------------------------------------------------------------------------------------------
  Characteristic                        Presumptive (%) \[Int. range\]   RDT\                 Microscopy\
                                                                         (%) \[Int. range\]   (%) \[Int. range\]
  ------------------------------------- -------------------------------- -------------------- --------------------
  Level at the health delivery system   Sub-county                       Sub-county           Sub-county

  Number of health centres per arm      5                                5                    5

  Total enrolment                       16971                            17637                17508

  Gender (female)                       10007(59.0)                      10045(57.0)          10440(59.6)

  Median age (in years)                                                                       

   \< 5 years                           2 \[1-3\]                        2 \[1-3\]            1.1 \[1-3\]

   ≥ 5 years                            21 \[13-34\]                     22 \[14-35\]         20 \[13-34\]

  Non-specific URTI                                                                           

   \< 5 years                           1554(52.9)                       1626(59.9)           1350(46.6)

   ≥ 5 years                            3635(25.9)                       5432(36.4)           2643(18.1)

  Otitis media                                                                                

   \< 5 years                           6(0.2)                           16(0.6)              20(0.7)

   ≥ 5 years                            24(0.2)                          8(0.1)               24(0.2)

  Sore throat                                                                                 

   \< 5 years                           24(0.8)                          8(0.3)               24(0.8)

   ≥ 5 years                            20(0.1)                          204(1.2)             136(0.9)
  ----------------------------------------------------------------------------------------------------------------

Int. range = inter-quartile range, RDT = rapid diagnostic test, URTI = upper respiratory tract infection

Types of antibiotics prescribed
-------------------------------

Oral co-trimoxazole was prescribed to 11,862 patients (51.0%) and amoxicillin capsules to 5,986 (25.8%). These two antibiotics were the most commonly prescribed. Metronidazole was prescribed to 3,950 patients (17.0%), but in combination with other antibiotics. Doxycycline, erythromycin and ciprofloxacin were also prescribed, but in smaller quantities. Other drugs such as analgesics and anti-helminthics were prescribed to 49,574 patients (95.2%) and 10,330 (19.8%) respectively.

Antibiotic use in patients who did not receive a parasitological test for malaria
---------------------------------------------------------------------------------

In the presumptive arm 7,040 patients (41.5%) were prescribed antibiotics. In the microscopy arm 6,427 (37%) did not receive a parasitological diagnosis and of these 1,537 (23.9%) were prescribed antibiotics. In the RDT arm, 1442 (8%) did not receive a parasitological diagnosis and of these 810 (56.2%) were prescribed antibiotics (Figure [1](#F1){ref-type="fig"}). Prescription of antibiotics was more common for children less than five years of age as compared to those who were older (Table [2](#T2){ref-type="table"}). The pattern of antibiotic prescription varied widely across health units: presumptive arm (range 40.7% to 42.2%), microscopy arm (range 22.9% to 25.0%) and in RDT arm (range 53.6% to 58.7%). Overall 9387 (38%) of the patients who did not receive a parasitological diagnosis were prescribed antibiotics.

###### 

Prescription of antibiotics in patients who did not receive parasitological diagnosis stratified by diagnostic method, age and health centre

  ----------------------------------------------------------------------------------------------------
  Diagnostic method   \< 5 years\                ≥ 5 years\                 Total\
                      n(%)\[95%CI\]              n(%)\[95%CI\]              n(%)\[95%CI\]
  ------------------- -------------------------- -------------------------- --------------------------
  **Presumptive**                                                           

  Karungu             372(69.9) \[66.0-73.8\]    1327(39.0) \[37.4-40.7\]   1699(43.2) \[41.6-44.7\]

  Kashenshero         \*                         1136(34.7) \[33.1-36.3\]   1136(34.7) \[33.0-36.3\]

  Katunguru           376(59.5) \[55.7-63.3\]    1418(45.9) \[44.1-47.6\]   1794(48.2) \[46.6-49.8\]

  Kyangyenyi          1000(56.6) \[54.2-58.9\]   238 (25.6) \[22.8-28.4\]   1238(45.9) \[44.0-47.8\]

  Mutara              \*                         1173(35.2) \[33.6-36.8\]   1173(35.2) \[33.5-36.8\]

  Total               1748(59.5) \[57.8-61.3\]   5292(37.7) \[36.9-38.5\]   7040(41.5) \[40.7-42.2\]

  **RDT**                                                                   

  Burere              20(76.9) \[59.6-94.3\]     148(56.1) \[50.9-62.1\]    168(57.9) \[52.2-63.7\]

  Bushenyi            27(79.4) \[65.1-93.7\]     131(51.8) \[45.6-58.0\]    158(55.1) \[49.3-60.8\]

  Katerera            20(76.9) \[59.6-94.3\]     123(51.0) \[44.7-57.4\]    143(53.6) \[47.5-59.6\]

  Kyamuhumga          26(72.2) \[56.9-87.6\]     184(54.8) \[49.4-60.1\]    210(56.5) \[51.4-61.5\]

  Kyeizoba            15(65.2) \[44.2-86.3\]     116(57.1) \[50.3-64.0\]    131(58.0) \[51.5-64.4\]

  Total               108(74.5) \[67.3-81.7\]    702(54.1) \[51.4-56.8\]    810(56.2) \[53.6-58.7\]

  **Microscopy**                                                            

  Bugongi             81(43.1) \[35.9-50.2\]     146(13.7) \[11.7-15.8\]    227(18.1) \[16.0-20.3\]

  Kabira              123(47.3) \[41.2-53.4\]    208(18.3) \[16.0-20.5\]    331(23.7) \[21.4-25.9\]

  Kabushaho           130(54.9) \[48.5-61.2\]    234(21.0) \[18.6-23.4\]    364(26.9) \[24.6-29.3\]

  Kichwamba           123(54.7) \[48.1-61.2\]    216(23.8) \[21.1-26.6\]    339(30.0) \[27.3-32.6\]

  Kigarama            107(48.2) \[41.6-54.8\]    169(15.8) \[13.6-17.9\]    276(21.3) \[19.1-23.6\]

  Total               564(49.8) \[46.9-52.7\]    973(18.4) \[17.3-19.4\]    1537(23.9) \[22.9-25.0\]
  ----------------------------------------------------------------------------------------------------

CI = confidence interval, RDT = rapid diagnostic test, \*children under-five records missing

Antibiotic treatment in patients with a positive RDT or microscopy
------------------------------------------------------------------

Of the 3,313 patients who tested positive for malaria in the RDT arm, 854 (25.8%) were prescribed antibiotics. In the microscopy arm of the 1,548 with positive results, 273 (17.6%) were prescribed antibiotics (Table [3](#T3){ref-type="table"}). Patients under five years were more often prescribed antibiotics than in those five years and above in both RDT and microscopy arms. Prescription of antibiotics also varied widely between health units (ranging from 15.7% to 27.3%).

###### 

Prescription of antibiotics in patients with positive RDT or microscopy by age and health centre

  -------------------------------------------------------------------------------------------------
  Diagnostic method   \< 5 years\               ≥ 5 years\                Total\
                      n(%)\[95%CI\]             n(%)\[95%CI\]             n(%)\[95%CI\]
  ------------------- ------------------------- ------------------------- -------------------------
  **RDT**                                                                 

  Burere              50(42.7) \[33.6-51.8\]    104(19.4) \[16.0-22.8\]   154(23.6) \[20.3-26.8\]

  Bushenyi            29(33.3) \[23.2-43.4\]    82(17.9) \[14.4-21.5\]    111(20.4) \[17.0-23.8\]

  Katerera            47(45.2) \[35.5-54.9\]    115(21.3) \[17.9-24.8\]   162(25.2) \[21.8-28.6\]

  Kyamuhumga          84(54.2) \[46.3-62.1\]    162(25.8) \[22.3-29.2\]   246(31.4) \[28.1-34.6\]

  Kyeizoba            43(35.8) \[27.1-44.5\]    138(24.3) \[20.7-27.8\]   181(26.3) \[23.0-29.6\]

  Total               253(43.4) \[39.4-47.4\]   601(22.0) \[20.5-23.6\]   854(25.8) \[24.3-27.3\]

  **Microscopy**                                                          

  Bugongi             17(34.7) \[20.9-48.5\]    36(14.2) \[9.9-18.6\]     53(17.6) \[13.2-21.9\]

  Kabira              23(37.7) \[25.2-50.2\]    38(12.8) \[8.9-16.6\]     61(17.0) \[13.1-20.9\]

  Kabushaho           16(38.1) \[22.8-53.4\]    30(12.1) \[8.0-16.2\]     46(15.9) \[11.6-20.1\]

  Kichwamba           26(41.9) \[29.3-54.6\]    39(13.8) \[9.8-17.9\]     65(18.9) \[14.7-23.1\]

  Kigarama            23(41.8) \[28.4-55.3\]    25(12.6) \[8.0-17.3\]     48(19.0) \[14.1-23.8\]

  Total               105(39.0) \[33.2-44.9\]   168(13.1) \[11.3-15.0\]   273(17.6) \[15.7-19.5\]
  -------------------------------------------------------------------------------------------------

CI = confidence interval, RDT = rapid diagnostic test

Antibiotic use in patients with negative RDT or microscopy
----------------------------------------------------------

Overall, 11,658 patients (52.1%) with negative results were prescribed antibiotics (Table [4](#T4){ref-type="table"}). Patients with negative RDT 7,909 (61.4%) received antibiotics prescription more often than those with negative microscopy results 3,749 (39.3%) \[RR: 1.56; 95%CI: 1.41-1.73, *p*\< 0.001\]. Again children under five years of age with negative results in both RDT and microscopy arms were more often prescribed antibiotics than the older age group. Further, antibiotic prescription varied widely across health units (ranging from 38.4% to 62.4%).

###### 

Prescription of antibiotics in patients with negative RDT or microscopy by age and health centre

  ----------------------------------------------------------------------------------------------------
  Diagnostic method   \< 5 years\                All age ≥ 5 years\         Total\
                      n(%)\[95%CI\]              n(%)\[95%CI\]              n(%)\[95%CI\]
  ------------------- -------------------------- -------------------------- --------------------------
  **RDT**                                                                   

  Burere              299(80.0) \[75.6-83.8\]    1258(58.5) \[56.4-60.6\]   1557(61.7) \[59.8-63.6\]

  Bushenyi            180(81.1) \[75.9-86.3\]    767(54.0) \[51.4-56.6\]    947(57.7) \[55.3-60.1\]

  Katerera            285(82.6) \[78.6-86.6\]    1190(63.0) \[60.8-65.2\]   1475(66.1) \[64.1-68.0\]

  Kyamuhumga          485(81.1) \[78.0-84.3\]    1826(60.8) \[59.0-62.5\]   2311(64.2) \[62.6-65.7\]

  Kyeizoba            353(79.0) \[75.2-82.8\]    1266(52.8) \[50.8-54.7\]   1619(56.9) \[55.1-58.7\]

  Total               1602(80.6) \[78.9-82.4\]   6307(58.1) \[57.1-60.0\]   7909(61.6) \[60.7-62.4\]

  **Microscopy**                                                            

  Bugongi             202(64.9) \[59.6-70.3\]    470(29.8) \[27.5-32.0\]    672(35.5) \[33.4-37.7\]

  Kabira              213(65.5) \[60.3-70.7\]    543(32.7) \[30.4-34.9\]    756(38.0) \[35.9-40.2\]

  Kabushaho           207(70.7) \[65.4-75.9\]    570(36.8) \[34.4-39.2\]    777(42.2) \[39.9-44.5\]

  Kichwamba           189(70.3) \[64.8-75.8\]    572(39.4) \[36.9-41.9\]    761(44.2) \[41.9-46.6\]

  Kigarama            195(64.9) \[59.6-70.4\]    590(33.0) \[30.9-35.2\]    785(37.6) \[35.5-39.7\]

  Total               1006(67.2) \[64.8-69.5\]   2745(34.2) \[33.2-35.2\]   3751(39.4) \[38.4-40.4\]
  ----------------------------------------------------------------------------------------------------

CI = confidence interval, RDT = rapid diagnostic test

Discussion
==========

This article reports on a large assessment of the effect of malaria diagnostics on the probability of receiving antibiotics in a Ugandan population living in an area of unstable malaria transmission. The findings indicate that the rate of antibiotic treatment was high; there was a reduction in antibiotic prescription among patients with positive malaria test results; there was an increase in antibiotic treatment in those testing negative; the rate of antibiotic prescription was higher in children under five years of age; and antibiotic prescription varied widely across HCs suggesting that prescribers\' behaviour is a big factor in use of antibiotics.

The level of antibiotic treatment reported here is higher than that demonstrated in Kabale \[[@B15]\], a district in the same region of Uganda with similar malaria endemicity, but comparable to that reported in Zanzibar \[[@B16]\]. In this study it is unlikely that symptoms alone justify this rate of antibiotic prescription as less than 5% of the patients would probably need antibiotics based on the clinical presentation. Other reasons such as expectations of the patient \[[@B17]\], service provider (prescriber) behaviour \[[@B18]\] and the social interaction between the patient and prescriber \[[@B17],[@B18]\] have been cited. It was reported that for a satisfactory outcome of the consultation process, the clinician provides technically correct care, but this corresponds with the patient\'s expectations in order to legitimize the illness \[[@B18]\]. Also an earlier study \[[@B19]\] demonstrated that patient preference can stimulate inappropriate antibiotic prescribing. Further, other studies provided information about the other reasons for unnecessary antibiotic use \[[@B20]-[@B22]\]. Of particular importance are the inadequate staffing and the varying levels of professional training of staff manning outpatient clinics reported in a previous publication \[[@B12]\]. Understaffing is impacted by the heavy patient load, creating a need to finish the queue at the earliest possible time. Some reports also indicated that overuse of medicines is a consequence of diagnostic uncertainty by service providers, inappropriate unethical promotion of medicines by pharmaceutical companies, overworked health staff with limited time to spend with patients, and unrestricted availability of medicines \[[@B2],[@B21],[@B23]\]. These results complement these observations as diagnostic uncertainty and prescribers\' behaviour were important determinants of antibiotic use in this study.

Patients who were in the RDT arm were more likely than those in the microscopy arm to be prescribed antibiotics. This difference is unlikely to be attributed to use of RDT. Generally in the microscopy arm, antibiotic prescription was low among: those not tested, who tested positive and those who tested negative. The trend of antibiotic use, however, was similar in the two diagnostic arms (decreasing among patients who test positive and increasing among negative patients). A more likely explanation for this difference in rates of antibiotic use among the diagnostic arms is prescribers\' behaviour \[i.e. higher likelihood of service providers more likely to treat with antibiotics in the RDT arm\].

The rate of antibiotic prescription generally decreased among patients with positive results. This might indicate clinicians\' acceptance of malaria-positive results as the only likely cause of illness at that point and therefore restrained from prescribing concurrent medications. However, the proportion of parasitaemic patients prescribed antibiotics reported here is higher than that observed in other settings \[[@B24]\]. Enormous resources have been invested in improving the targeting of anti-malarials but the concern of concurrent or otherwise antibiotic treatment has not received equal attention. Although antibiotic prescription to febrile outpatients appears complex because of frequent presentation with multiple complaints, antibiotic treatment in parasitaemic patients may be an indicator of the likely inability to utilize the clinical guidelines. Antibiotic prescribing for cough or non-specific upper respiratory tract infections was reported to be neither cost-effective nor cough-effective \[[@B25]\]. Therefore, there is need to enhance the treatment decisions at the lower level of care since staff manning these units have varying levels of professional training.

In this study, the chance of prescribing antibiotics increased if a febrile patient tested negative for malaria. These data are similar to what has been reported elsewhere \[[@B24],[@B26]-[@B28]\]. Thus it appears that there is a compensatory antibiotic prescription in patients with negative results. This scenario of antibiotic prescribing has the potential to erode the financial savings that could accrue from widespread implementation of the universal \'test and treat\' strategy for malaria. Besides the universal test and treat strategy does not provide adequate guidance on treating patients who test negative for malaria. Therefore, there is need to develop and implement guidelines regarding antibiotic treatment in febrile patients who test negative for malaria.

In some settings, interventions that promote rational antibiotic use have been shown to be effective. These emphasize careful diagnosis especially of upper respiratory syndromes, deferral of antibiotic use, and a watch-and-wait approach (along with symptom relief) for which antibiotics are not immediately indicated \[[@B29]\], and a targeted educational intervention \[[@B30]\]. Unless the use of antibiotics is curtailed, there is a prospect of higher costs, increased morbidity, and higher rates of death from common bacterial infections \[[@B2]\].

Conclusions
===========

Prescription of antibiotics in patients with febrile illness is high. Testing for malaria reduces antibiotic treatment in patients with positive results but increases in those testing negative. Antibiotic use also depends on age and prescriber behaviour. It is essential that malaria diagnostics are rolled-out in all primary level health units and guidelines for antibiotic treatment especially among children developed and distributed. In addition, continuing professional education for prescribers should be enforced.
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